Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Common montelukast (Singulair) side effects include headache, stomach pain, nausea, diarrhea, cough, upper respiratory infection symptoms, fever, and tiredness, while less common effects can involve rash, dizziness, and sleep problems. More serious neuropsychiatric reactions such as agitation, anxiety, depression, unusual dreams, irritability, and suicidal thinking have prompted an FDA boxed warning, and these can appear in both children and adults. Severity, timing, and risk factors vary widely from person to person, so there are several important details to consider before deciding whether to continue or stop the medication. See below to understand more, including which symptoms warrant urgent medical attention.
If you are noticing new symptoms while taking montelukast, it can be hard to tell whether the drug is the cause, your asthma or allergies are flaring, or something else entirely is going on, and that distinction changes what you should do next. A free, instant, online symptom check can help you sort through your specific symptoms, understand possible explanations, and see how urgently you should speak with a clinician before your next dose.
Last reviewed for medical accuracy: 09/24/2026
Montelukast is a prescription medication often used to prevent and manage asthma symptoms and to relieve seasonal or year-round allergic rhinitis (hay fever). It belongs to a class of drugs called leukotriene receptor antagonists, which work by blocking substances in the body (leukotrienes) that trigger inflammation, bronchoconstriction (tightening of the airways), and excessive mucus production (DailyMed, FDA). While montelukast can be highly effective for many patients, it can also cause side effects. Understanding these helps you recognize what’s normal and when to seek medical attention.
Montelukast blocks leukotriene receptors in the lungs and airways. By doing so, it:
You usually take montelukast once daily, with or without food. It’s not intended to treat sudden asthma attacks—you still need a fast-acting inhaler for that.
Most people tolerate montelukast well. The most frequently reported side effects are mild and may lessen over time as your body adjusts. Common montelukast side effects include:
(Source: Mayo Clinic; DailyMed, FDA)
While less frequent than the above, these side effects still occur in a small percentage of users:
If these symptoms persist or worsen, mention them to your healthcare provider at your next visit.
Serious reactions are uncommon, but you should be aware of them. Seek immediate medical attention if you notice any of the following:
(These events are very rare—often linked to tapering off oral steroids rather than montelukast itself—but remain on the FDA’s watch list.)
One of the more publicized concerns with montelukast involves mood and behavior changes. Reported neuropsychiatric side effects include:
If you or a loved one experiences any sudden changes in mood or behavior, stop the medication and contact your healthcare provider right away (FDA Safety Communication).
Here are some practical tips to minimize discomfort and ensure safe use:
Most side effects diminish after the first few weeks. However, you should speak to a doctor if you experience:
For a quick check on your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide how urgently to seek medical care.
Montelukast offers relief for many individuals struggling with asthma or allergies, and most people experience only mild side effects. Staying informed, adhering to your prescribed dose, and maintaining open communication with your healthcare provider are key to a safe, effective treatment plan.
If you notice anything unusual—particularly severe or life-threatening reactions—stop montelukast and speak to a doctor right away. Your health and well-being always come first.
(References)
* Rokni GR, Mohammadnezhad F, Saeedi M, Shadi S, Sharma A, Sandhu S, Gupta A, Goldust M. Efficacy, tolerability, and safety of montelukast versus finasteride for the treatment of moderate acne in women: A prospective, randomized, single-blinded, active-controlled trial. J Cosmet Dermatol. 2021 Nov;20(11):3580-3585. doi: 10.1111/jocd.14462. Epub 2021 Oct 14. PMID: 34648685.
* Jordan A, Toennesen LL, Eklöf J, Sivapalan P, Meteran H, Bønnelykke K, Ulrik CS, Stæhr Jensen JU. Psychiatric Adverse Effects of Montelukast-A Nationwide Cohort Study. J Allergy Clin Immunol Pract. 2023 Jul;11(7):2096-2103.e1. doi: 10.1016/j.jaip.2023.03.010. Epub 2023 Mar 21. PMID: 36948487.
* Lo CWH, Pathadka S, Qin SX, Fung LWY, Yan VKC, Yiu HHE, Bloom CI, Wong ICK, Chan EWY. Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review. Eur Respir Rev. 2023 Sep 30;32(169). doi: 10.1183/16000617.0079-2023. Epub 2023 Sep 27. PMID: 37758273; PMCID: PMC10523155.
* ALMuhizi F, De Las Vecillas Sanchez L, Gilbert L, Copaescu AM, Isabwe GAC. Premedication Protocols to Prevent Hypersensitivity Reactions to Chemotherapy: a Literature Review. Clin Rev Allergy Immunol. 2022 Jun;62(3):534-547. doi: 10.1007/s12016-022-08932-2. Epub 2022 Mar 8. PMID: 35258842.
* Montelukast. 2006. PMID: 30000548.
* Drugs for asthma. Med Lett Drugs Ther. 2024 Nov 25;66(1716):185-192. doi: 10.58347/tml.2024.1716a. PMID: 39558440.
* Goldstein MF, Anoia J, Black M. Montelukast-induced hepatitis. Ann Intern Med. 2004 Apr 6;140(7):586-7. doi: 10.7326/0003-4819-140-7-200404060-00042. PMID: 15069001.
* Al-Shamrani A, Alharbi S, Kobeisy S, AlKhater SA, Alalkami H, Alahmadi T, Almutairi A, Alharbi AS, Yousef AA. Adverse Drug Reactions (ADRs) of Montelukast in Children. Children (Basel). 2022 Nov 21;9(11). doi: 10.3390/children9111783. Epub 2022 Nov 21. PMID: 36421233; PMCID: PMC9688958.
* Mao M, Wang M, Yu Q, Chen Q, Zhu H, Wan T, Yang Y, Zhao J. Updated insights on memory disorder associated risk of medication: A real-world pharmacovigilance analysis. J Affect Disord. 2025 Dec 1;390:120064. doi: 10.1016/j.jad.2025.120064. Epub 2025 Aug 13. PMID: 40816367.
* Minciullo PL, Saija A, Bonanno D, Ferlazzo E, Gangemi S. Montelukast-induced generalized urticaria. Ann Pharmacother. 2004 Jun;38(6):999-1001. doi: 10.1345/aph.1D547. Epub 2004 Apr 27. PMID: 15113985.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.